
TSE:MFC
This summary was created by AI, based on 27 opinions in the last 12 months.
Manulife Financial (MFC-T) has shown resilience and growth, particularly in Asia and wealth management, despite recent challenges such as a new tax on its products in Mainland China. The stock appears to be experiencing a phase of high expectations, as evidenced by its notable ranking among Canadian equities. While some experts express caution due to valuations approaching overbought territory, they also recognize MFC's solid fundamentals, including a healthy dividend yield and strong asset management. However, the stock has prompted mixed sentiments regarding its potential for further gains amidst a dynamic financial landscape, with some analysts suggesting it may be time to accumulate shares during a market pullback. Overall, the stock's performance is closely watched, with a general understanding that lower interest rates and strategic positioning may lead to a continued upward trajectory.
He respects their business and what they are doing in terms of being global, especially with their exposure in China. It also pays a dividend. All of that is positive. The issue he has is that it is a hard stock to make money on. They recently reported earnings having a strong quarter. With their dividend of about 3.3% and trading at 11 or 12 times, that yield and Price to earnings valuation is very much in line with where Canadian banks are right now, and he would rather own Canadian banks.
The insurance company he would be a buyer of today. The nice thing is the global diversification. You are getting the US business, the asset manager and the underwriting life insurance business, but more importantly you are getting the Asian exposure, in particular China. If you just tuck this away, as rates creep higher globally and the insurance markets heal, it’s a company you need to own.
He likes the insurers, and feels they are undervalued at this stage. This is trading at about 10X forward earnings, and BV is just over 1.1 or 1.2. Also, pays a pretty decent dividend of 3.4%. The reason it has dropped off along with other insurers is that there has been a bit of a scale back on long-term interest rates, and insurers are really based on where interest rates are going on the 5 and 10 year rates. He likes their exposure in Japan and other parts of Asia.
He likes this company. There was a run up last year on the anticipation of higher interest rates and inflation coming back. That didn’t happen, so the stock has calmed down. Earnings are being reported, and they are good and solid. ROE of about 11%-12%. He likes this longer-term, because it is capital market intensive as well as their growth in Asia.
Canadian Banks versus lifecos? He is a bigger fan of the lifecos. Manulife (MFC-T) and Sun Life (SLF-T) are going to get a big boost from rising interest rates. It is already starting to happen. The yield curve is steepening. Lifecos have been suffering and living with low interest rates for a long time. Both companies are also quite global. They have big presences in the US and in Asia. He sees a better earnings growth over the next few years.
Move into banks instead? He likes the banks more. This company’s story on paper is pretty good. They’ve gone from being insurance centric to wealth management, which has that reoccurring fees. They’ve done a lot of things well. Interest rates are eventually going to go up, and this company is going to benefit. However, if you are not making money for your shareholders, it is a waste of time. He would make that move.
Bought this for his equity platform on its break-out in late 2016, and sold it in the early part of this year. He still holds it in his income platform because it has a pretty darn good dividend. Doesn’t think there is a lot of downside. If you are happy holding the stock and collecting the dividend, there is going to be a fair amount of support at around $22, and he wouldn’t worry about it.